Dicerna Pharmaceuticals Inc
F:DPL
Income Statement
Earnings Waterfall
Dicerna Pharmaceuticals Inc
Income Statement
Dicerna Pharmaceuticals Inc
| Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Revenue |
7
N/A
|
6
-4%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+81%
|
0
N/A
|
0
N/A
|
0
-55%
|
1
+692%
|
3
+150%
|
4
+60%
|
6
+38%
|
6
+9%
|
8
+25%
|
12
+53%
|
18
+55%
|
24
+30%
|
55
+129%
|
90
+63%
|
130
+46%
|
164
+26%
|
178
+8%
|
179
+0%
|
193
+8%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(16)
|
(16)
|
(18)
|
(22)
|
(30)
|
(37)
|
(45)
|
(51)
|
(56)
|
(62)
|
(63)
|
(65)
|
(64)
|
(62)
|
(60)
|
(59)
|
(56)
|
(54)
|
(54)
|
(65)
|
(59)
|
(64)
|
(71)
|
(84)
|
(101)
|
(125)
|
(152)
|
(180)
|
(222)
|
(253)
|
(278)
|
(295)
|
(303)
|
(314)
|
|
| Selling, General & Administrative |
(4)
|
(5)
|
(6)
|
(8)
|
(11)
|
(13)
|
(16)
|
(18)
|
(18)
|
(20)
|
(19)
|
(18)
|
(18)
|
(18)
|
(18)
|
(19)
|
(19)
|
(19)
|
(18)
|
(20)
|
(21)
|
(22)
|
(25)
|
(27)
|
(31)
|
(36)
|
(43)
|
(49)
|
(61)
|
(67)
|
(72)
|
(77)
|
(82)
|
(87)
|
|
| Research & Development |
(11)
|
(11)
|
(12)
|
(14)
|
(19)
|
(24)
|
(29)
|
(33)
|
(38)
|
(43)
|
(44)
|
(47)
|
(46)
|
(44)
|
(42)
|
(39)
|
(37)
|
(36)
|
(36)
|
(37)
|
(38)
|
(41)
|
(46)
|
(57)
|
(70)
|
(88)
|
(109)
|
(131)
|
(161)
|
(186)
|
(205)
|
(218)
|
(221)
|
(227)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(9)
N/A
|
(9)
0%
|
(18)
-92%
|
(22)
-26%
|
(30)
-34%
|
(37)
-24%
|
(45)
-22%
|
(51)
-13%
|
(56)
-10%
|
(62)
-10%
|
(63)
-2%
|
(65)
-3%
|
(64)
+1%
|
(61)
+4%
|
(60)
+3%
|
(58)
+3%
|
(56)
+4%
|
(54)
+3%
|
(53)
+2%
|
(62)
-18%
|
(55)
+12%
|
(58)
-5%
|
(64)
-11%
|
(77)
-19%
|
(89)
-16%
|
(106)
-19%
|
(128)
-21%
|
(125)
+2%
|
(133)
-6%
|
(123)
+7%
|
(113)
+8%
|
(117)
-3%
|
(124)
-6%
|
(121)
+2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
5
|
7
|
8
|
8
|
8
|
7
|
6
|
4
|
2
|
1
|
|
| Non-Reccuring Items |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(5)
|
(8)
|
0
|
(28)
|
(29)
|
(26)
|
(26)
|
(4)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(7)
|
(7)
|
(3)
|
|
| Pre-Tax Income |
(10)
N/A
|
(10)
-3%
|
(19)
-80%
|
(26)
-38%
|
(33)
-30%
|
(40)
-21%
|
(48)
-20%
|
(51)
-7%
|
(56)
-9%
|
(62)
-10%
|
(63)
-2%
|
(64)
-3%
|
(64)
+1%
|
(61)
+4%
|
(60)
+3%
|
(58)
+3%
|
(58)
+1%
|
(58)
-1%
|
(60)
-3%
|
(62)
-2%
|
(82)
-33%
|
(86)
-5%
|
(89)
-3%
|
(99)
-12%
|
(88)
+12%
|
(99)
-13%
|
(120)
-21%
|
(117)
+3%
|
(125)
-7%
|
(116)
+7%
|
(113)
+3%
|
(120)
-7%
|
(129)
-7%
|
(123)
+4%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
(10)
|
(10)
|
(19)
|
(26)
|
(33)
|
(40)
|
(48)
|
(51)
|
(56)
|
(62)
|
(63)
|
(64)
|
(64)
|
(61)
|
(60)
|
(58)
|
(58)
|
(58)
|
(60)
|
(62)
|
(82)
|
(86)
|
(89)
|
(99)
|
(88)
|
(99)
|
(120)
|
(117)
|
(125)
|
(116)
|
(113)
|
(120)
|
(129)
|
(124)
|
|
| Net Income (Common) |
(10)
N/A
|
(10)
-3%
|
(19)
-80%
|
(26)
-38%
|
(33)
-30%
|
(40)
-21%
|
(48)
-20%
|
(51)
-7%
|
(56)
-9%
|
(62)
-10%
|
(63)
-2%
|
(64)
-3%
|
(64)
+1%
|
(61)
+4%
|
(60)
+3%
|
(58)
+3%
|
(58)
+1%
|
(58)
-1%
|
(60)
-3%
|
(62)
-2%
|
(82)
-33%
|
(86)
-5%
|
(89)
-3%
|
(99)
-12%
|
(88)
+12%
|
(99)
-13%
|
(120)
-21%
|
(117)
+3%
|
(125)
-7%
|
(116)
+7%
|
(113)
+3%
|
(120)
-7%
|
(129)
-7%
|
(124)
+4%
|
|
| EPS (Diluted) |
-0.94
N/A
|
-0.97
-3%
|
-1.74
-79%
|
-2.36
-36%
|
-1.47
+38%
|
-2.26
-54%
|
-2.67
-18%
|
-2.87
-7%
|
-2.97
-3%
|
-3
-1%
|
-2.62
+13%
|
-3.12
-19%
|
-3.08
+1%
|
-2.95
+4%
|
-2.87
+3%
|
-2.79
+3%
|
-2.77
+1%
|
-2.81
-1%
|
-2.39
+15%
|
-1.19
+50%
|
-1.56
-31%
|
-1.57
-1%
|
-1.4
+11%
|
-1.46
-4%
|
-1.28
+12%
|
-1.45
-13%
|
-1.75
-21%
|
-1.6
+9%
|
-1.69
-6%
|
-1.55
+8%
|
-1.5
+3%
|
-1.58
-5%
|
-1.68
-6%
|
-1.6
+5%
|
|